Profile
Sector:
HealthcareCountry:
United StatesIPO:
23 May 2014Website:
http://www.agiletherapeutics.comNext earnings report:
08 November 2024Last dividends:
N/ANext dividends:
N/ADividend
Analysts recommendations
Institutional Ownership
Included in screeners
Similar companies
AGRX Latest News
PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Thursday, March 28, 2024.
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Friday, March 22, 2024.
Agile is seeing strong revenue growth. The company only has one marketed product, a birth control patch.
Agile Therapeutics, Inc. (NASDAQ:AGRX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Matt Riley - Head, Investor Relations Al Altomari - Chairman & Chief Executive Officer Conference Call Participants Oren Livnat - H.C. Wainwright Operator Good day, and thank you for standing by.
What type of business is Agile Therapeutics?
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. As of August 26, 2024, Agile Therapeutics, Inc. operates as a subsidiary of Exeltis USA, Inc.
What sector is Agile Therapeutics in?
Agile Therapeutics is in the Healthcare sector
What industry is Agile Therapeutics in?
Agile Therapeutics is in the Drug Manufacturers - Specialty & Generic industry
What country is Agile Therapeutics from?
Agile Therapeutics is headquartered in United States
When did Agile Therapeutics go public?
Agile Therapeutics initial public offering (IPO) was on 23 May 2014
What is Agile Therapeutics website?
https://www.agiletherapeutics.com
Is Agile Therapeutics in the S&P 500?
No, Agile Therapeutics is not included in the S&P 500 index
Is Agile Therapeutics in the NASDAQ 100?
No, Agile Therapeutics is not included in the NASDAQ 100 index
Is Agile Therapeutics in the Dow Jones?
No, Agile Therapeutics is not included in the Dow Jones index
When was Agile Therapeutics the previous earnings report?
No data
When does Agile Therapeutics earnings report?
The next expected earnings date for Agile Therapeutics is 08 November 2024